PALLA PHARMA NORWAY AS

3770 KRAGERØ

Finances

Share Ownership

Return on Equity

3 930,65 %

Current Ratio

1,94

Debt-to-Equity Ratio

−28,92

Key figures (NOK)	2022	2021	2020	2019
Revenue	83 926 000	97 211 000	117 995 000	286 196 000
Net Income	−74 761 000	−106 989 000	−97 984 000	−17 755 000
Total Assets	88 038 000	98 665 000	119 127 000	177 028 000
Total Equity	−1 902 000	−187 386 000	−80 397 000	17 588 000

Income (NOK)	2022	2021	2020	2019
Revenue	83 926 000	97 211 000	117 995 000	286 196 000
Expenditure	158 245 000	201 174 000	205 469 000	297 689 000
Operating Profit	−74 318 000	−103 962 000	−87 474 000	−11 493 000
Financial Income	1 101 000	2 533 000	29 000	84 000
Financial Costs	1 544 000	5 560 000	10 539 000	6 224 000
Financial Balance	−443 000	−3 027 000	−10 510 000	−6 140 000
Earnings Before Tax	−74 761 000	−106 989 000	−97 984 000	−17 633 000
Tax	0	0	0	122 000
Net Income	−74 761 000	−106 989 000	−97 984 000	−17 755 000

Balance (NOK)	2022	2021	2020	2019
Total Fixed Assets	20 224 000	21 823 000	17 350 000	19 305 000
Total Current Assets	67 814 000	76 842 000	101 777 000	157 723 000
Total Assets	88 038 000	98 665 000	119 127 000	177 028 000
Total Retained Equity	−4 902 000	−207 280 000	−100 291 000	−2 306 000
Total Equity	−1 902 000	−187 386 000	−80 397 000	17 588 000
Total Long-Term Debt	55 000 000	45 440 000	45 440 000	45 440 000
Total Current Debt	34 940 000	240 611 000	154 084 000	114 001 000
Total Equity and Debt	88 038 000	98 665 000	119 127 000	177 028 000

Cash flow (NOK)	2022	2021	2020	2019
Sales Income	83 238 000	97 111 000	116 465 000	286 148 000
Other Income	689 000	100 000	1 530 000	48 000
Revenue	83 926 000	97 211 000	117 995 000	286 196 000
Cost of Goods Sold	55 296 000	93 819 000	98 209 000	172 858 000
Salary Costs	59 044 000	60 225 000	47 492 000	60 725 000
Depreciation	3 312 000	3 641 000	3 789 000	3 599 000
Impairment	0	0	0	0
Expenditure	158 245 000	201 174 000	205 469 000	297 689 000
Operating Profit	−74 318 000	−103 962 000	−87 474 000	−11 493 000
Financial Income	1 101 000	2 533 000	29 000	84 000
Financial Costs	1 544 000	5 560 000	10 539 000	6 224 000
Financial Balance	−443 000	−3 027 000	−10 510 000	−6 140 000
Dividends	0	0	0	0
Net Income	−74 761 000	−106 989 000	−97 984 000	−17 755 000

Balance details (NOK)	2022	2021	2020	2019
Goodwill	0	0	0	0
Total Intangible Assets	56 000	182 000	274 000	431 000
Real Eastate	1 810 000	1 958 000	1 872 000	2 296 000
Machinery and Plant Facilities	16 957 000	18 264 000	14 018 000	14 711 000
Fixtures	1 401 000	1 419 000	1 186 000	1 867 000
Total Tangible Assets	20 168 000	21 641 000	17 076 000	18 873 000
Total Fiancial Fixed Assets	0	0	0	0
Total Fixed Assets	20 224 000	21 823 000	17 350 000	19 305 000
Stock	47 363 000	47 505 000	53 292 000	40 502 000
Total Investments	0	0	0	0
Cash, Bank	2 531 000	3 566 000	3 325 000	9 191 000
Total Current Assets	67 814 000	76 842 000	101 777 000	157 723 000
Total Assets	88 038 000	98 665 000	119 127 000	177 028 000
Total Equity	−1 902 000	−187 386 000	−80 397 000	17 588 000
Short-Term Group Debt	473 000	214 702 000	133 196 000	9 154 000
Total Long-Term Debt	55 000 000	45 440 000	45 440 000	45 440 000
Creditors	12 315 000	16 413 000	9 704 000	87 738 000
Unpaid Taxes	2 195 000	2 072 000	4 722 000	10 118 000
Dividends	0	0	0	0
Other Current Debt	10 066 000	7 423 000	6 462 000	6 991 000
Total Current Debt	34 940 000	240 611 000	154 084 000	114 001 000
Total Equity and Debt	88 038 000	98 665 000	119 127 000	177 028 000

Financial indicators	2022	2021	2020	2019
Return on Equity	3 930,65 %	57,1 %	121,88 %	−100,95 %
Debt-to-Equity Ratio	−28,92	−0,24	−0,57	2,58
Operating Profit Margin	−88,55 %	−106,94 %	−74,13 %	−4,02 %
Current Ratio	1,94	0,32	0,66	1,38
Quick Ratio	−5,46	0,4	1,01	2,15
Equity Ratio	−0,02	−1,9	−0,67	0,1
Gross Profit Margin	34,11 %	3,49 %	16,77 %	39,6 %